Visum Pharmaceutical develops, manufactures, and sells oral solid dosage medicines, including controlled-release formulations.
Founded in 2010 and based in Haikou, China, Visum Pharmaceutical develops, manufactures, exports, and sells medicines, with 2 manufacturing centers, 2 R&D centers, and 1 marketing center. It has 450 employees and develops more than 80 products, including controlled-release formulations and medicines such as metoprolol succinate extended-release tablets and quetiapine fumarate extended-release tablets. The company plans to continue R&D on high-end formulations and build new cGMP workshops.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in